The BrainSense Adaptive DBS system builds upon Medtronic's proprietary BrainSense technology, which detects, captures, and ...
For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...
The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...
In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
Similar to cranioelectrical stimulation, trans auricular vagus nerve stimulation shows dramatic potential to treat many brain ...
How to plan for unanticipated interactions during surgical energy device development that limit performance and frustrate ...